Penserra Capital Management’s AdaptHealth AHCO Stock Holding History

Penserra Capital Management’s Portfolio AHCO Stock Details AHCO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-3,921	Closed	-$70K	–	975
2022 Q2	$70K	Sell	3,921 -34	-0.9%	-$552	﹤0.01%	834
2022 Q1	$63K	Sell	3,955 -903	-19%	-$16.2K	﹤0.01%	950
2021 Q4	$118K	Sell	4,858 -4,716	-49%	-$111K	﹤0.01%	799
2021 Q3	$222K	Sell	9,574 -3,911	-29%	-$94.6K	﹤0.01%	601
2021 Q2	$369K	Sell	13,485 -3,711	-22%	-$106K	0.01%	544
2021 Q1	$632K	Buy	17,196 +4,935	+40%	+$174K	0.01%	420
2020 Q4	$460K	Buy	12,261 +10,573	+626%	+$327K	0.01%	387
2020 Q3	$39K	Buy	+1,688	New	+$35.4K	﹤0.01%	658

Other funds holding AHCO

OCA

OEP Capital Advisors New York $194M AUM 9.78% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

SkyKnight Capital San Francisco, California $107M AUM 9.69% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

RCMNY

Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return

SAM

Silvercrest Asset Management New York $13.8B AUM 28.39% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Penserra Capital Management's AHCO Position: Q3 2022 in Review

Penserra Capital Management sold out of AdaptHealth (AHCO) in Q3 2022, closing a stake of 3,921 shares — an estimated $70K sold.

Penserra Capital Management first reported a position in AHCO in Q3 2020 and held it in 8 quarters. The position peaked at $632K in Q1 2021. 184 funds tracked by Wall St. Rank hold AHCO as of Q3 2022.

Penserra Capital Management reported no remaining AdaptHealth position as of Q3 2022 after selling out during the quarter.
Penserra Capital Management sold 3,921 AdaptHealth shares in Q3 2022, an estimated $70K.
Penserra Capital Management first reported a position in AdaptHealth in Q3 2020 and held it in 8 quarters.
Penserra Capital Management's AdaptHealth position peaked at $632K in Q1 2021.
184 funds tracked by Wall St. Rank held AdaptHealth as of Q3 2022.

Based on Penserra Capital Management's 13F filing for Q3 2022, filed 14 Nov 2022.